BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$64.19
+4.02%Forward multiples
Based on analyst estimates
- P/E forward
- 9.99x
- P/E 2026E
- 9.77x
- P/E 2027E
- 9.46x
- P/E 2028E
- 11.82x
- P/S forward
- 2.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.20x
- PEG TTM
- 0.33x
- Price / book
- 5.61x
- Price / sales
- 2.62x
- Price / cash flow
- 12.32x
Enterprise value
- Enterprise value
- $163.4B
- EV / sales
- 3.27x
- EV / EBITDA
- 10.79x
- EV / EBIT
- 12.53x
- Market cap
- $131.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026